Navigation Links
Minorities Less Likely to Use Hospice Care: Study
Date:6/29/2012

FRIDAY, June 29 (HealthDay News) -- Minority patients with heart failure are less likely to use hospice care than whites, new research finds.

Hospice provides palliative care for the terminally ill. The goal is to ease pain and discomfort, and to focus on quality of life as death approaches. Overall, use of hospice care is increasing, according to researchers from Indiana University School of Medicine.

Their study found that nonwhite Medicare patients with heart failure were 20 percent less likely to enroll in hospice than white patients. Nonwhite patients were also more likely to drop out of hospice care than whites.

"When considering end-of-life care options, it is important to consider hospice services at home, in nursing homes or in hospice facilities," study author Dr. Kathleen Unroe, a scientist with the Indiana University Center for Aging Research, said in a university news release. "Our findings highlight that there is a significant difference between how white patients and nonwhite patients and their families utilize hospice services."

The study, which looked at records on nearly 220,000 heart failure patients on Medicare, was published in the June issue of the American Heart Journal.

Nearly 1.6 million people received hospice services in 2010, according to the National Hospice and Palliative Care Organization. About 42 percent of all deaths in the United States were under the care of a hospice program in 2010.

More information

The U.S. National Institutes of Health provides more information on hospice care.

-- Mary Elizabeth Dallas

SOURCE: Indiana University School of Medicine, news release, June 25, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Minorities, Medicare Recipients Less Likely to Get Antidepressants
2. C-Section Babies May Be More Likely to Fail First Hearing Test
3. Car crash victims more likely to survive if taken directly to a trauma centre
4. Patients with PsA treated with ustekinumab are twice as likely to achieve acr20 vs. placebo
5. Depressed Teens Who Respond to Treatment Less Likely to Abuse Drugs
6. City kids more likely to have food allergies than rural ones
7. Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo
8. Obese More Likely to Be Diagnosed With Advanced Thyroid Cancer
9. Genetic test identifies eye cancer tumors likely to spread
10. Individuals with dementia more likely to die at home than in nursing homes
11. Blacks Less Likely to Get Help on Scene After Cardiac Arrest: Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/25/2017)... , ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing ... acute or chronic problems, I focus on preventative care with all my patients to alleviate ... any questions, always feel free to contact my office and my trained staff will assist ...
(Date:4/25/2017)... ... 2017 , ... Amendia, Inc., designer, developer, and manufacturer of ... and platinum sponsorship of Global Spine Outreach (“GSO”), a charitable organization dedicated to ... spine deformity cases, particularly in children. , GSO’s focus is to provide hands-on ...
(Date:4/24/2017)... ... 2017 , ... Ridgecrest Herbals makes it a point to lead the Utah ... and support renewable energy. They believe this is a crucial part of their mission ... health issues, and maintain that destroying the environment in the pursuit of profit is ...
(Date:4/24/2017)... ... April 24, 2017 , ... The California Dental Association Foundation’s two-day volunteer ... to 1,961 people during the April 22-23 event at the San Mateo Event Center. ... experience barriers to care, CDA Cares educates the public and policymakers about the importance ...
(Date:4/24/2017)... ... April 24, 2017 , ... The world-class designers ... to bring their novel lifesaving device for the everyday use of parents worldwide. ... specially designed to read a child’s vital signs, and detect unusual symptoms or ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/18/2017)... , April 18, 2017 Cogentix Medical, Inc. ... providing the Urology, Uro/Gyn and Gynecology markets with innovative ... first quarter ended March 31, 2017 after the market ... The Company will host a conference call and webcast ... Tuesday, May 2, 2017 at 4:30 p.m. Eastern Time ...
(Date:4/18/2017)... BLOOMINGTON, Minn. , April 18, 2017 /PRNewswire/ ... ("Imprimis"), an ophthalmology-focused pharmaceutical company, and Cameron Ehlen ... the signing of a three-year exclusive sales representation ... a dedicated sales team to introduce Imprimis, ophthalmic ... focused in 13 states in the U.S. Midwest. Precision ...
Breaking Medicine Technology: